The challenges associated with managing multiple myeloma patients on immunotherapy
Ignacio Melero Bermejo
What we can learn about treating CLL from research on other cancers
Why should elderly AML patients take part in clinical trials?
The importance of the life cycle of CLL cells and how it can inform treatment
The 20th anniversary of the German CLL Study Group and the importance of collaboration